Chapter 89: Research End-notes

Thomas W Hilgers

Restorative Reproductive Medicine · NaProTechnology

Chapter 89: Research End-notes

Hilgers TW

The Medical and Surgical Practice of NaProTECHNOLOGY, 2004

RRM Academy Synopsis

NaProTECHNOLOGY research spans 8,622 patients and 209,469 observations

The research program behind NaProTECHNOLOGY gathered 209,469 research observations in 8,622 patients. The closing chapter of the 2004 textbook follows the program from its 1976 start in St. Louis through Creighton University to the Pope Paul VI Institute.

Key Findings

The program recorded 36,575 patient research contacts, spanning topics from Creighton Model System charting through surgery, infertility, endometriosis and pregnancy loss.
The chapter reports an additional 432 cycles in which ultrasound showed follicle rupture, each correlated with the Peak Day.
Hormone patterns in ovulation disorders, endometriosis, polycystic ovaries, pelvic adhesive disease and tubal occlusion were compared with those of women who ovulated normally by ultrasound criteria.
During the first 39 years of oral contraceptive availability, well over 100,000 studies were published, yet only two were double-blind, placebo-controlled studies of the pill's effectiveness in treating any medical illness.
Vulvar mucus observation, standardized at the start of the program, has more than 25 years of clinical application in every U.S. state and several other countries.

RRM Context

Restorative reproductive medicine looks for the underlying cause of a problem and then treats that cause. The chapter describes NaProTECHNOLOGY in the same terms: make a good diagnosis, then treat the problem. The Creighton Model System records daily observations in one standard form, so cycles can be compared across patients. The program used these standardized records to evaluate and treat women from before conception through full-term pregnancy, which the chapter calls periconceptional medicine.

Our editorial summary of this paper, not the article's abstract.

Abstract

A comprehensive, thematically organized compendium of citations documents the evidentiary foundations for every clinical protocol and outcome claim presented across the preceding 88 chapters, spanning foundational cervical mucus research through contemporary reproductive endocrinology and surgical outcomes literature. Consolidating this reference architecture in a dedicated chapter provides practitioners and researchers a structured pathway to primary literature, reinforcing that NaProTECHNOLOGY is grounded in a reproducible, peer-reviewed evidence base rather than institutional convention.

Topics

Restorative Reproductive Medicine NaProTechnology Protocols and Framework

Restorative Reproductive Medicine › NaProTechnology › Protocols and Framework

Thomas W Hilgers

Tom Hilgers, T Hilgers

Hilgers et al. 2004, Hilgers 2004

Chapter 89: Research End-notes

NaProTECHNOLOGY research spans 8,622 patients and 209,469 observations

Key Findings

RRM Context

Abstract

Topics

By this author

Related research